根据美国证券交易委员会(SEC)最新披露的文件,截至2025年12月31日,Empery资产管理有限公司(Empery Asset Management Lp)已持有生物科技公司Precision BioSciences Inc(简称:Precision BioSciences)9.99%的被动股权。该持股比例已接近10%的申报门槛,反映出机构投资者对Precision BioSciences业务前景的关注。
根据美国证券交易委员会(SEC)最新披露的文件,截至2025年12月31日,Empery资产管理有限公司(Empery Asset Management Lp)已持有生物科技公司Precision BioSciences Inc(简称:Precision BioSciences)9.99%的被动股权。该持股比例已接近10%的申报门槛,反映出机构投资者对Precision BioSciences业务前景的关注。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.